Omeros | OMER - Ativos





Ativos Alterar Data
Adma Biologics USD 665.18M 40.94M 2026-03
Alnylam Pharmaceuticals USD 5.13B 163.22M 2026-03
BioMarin Pharmaceutical USD 8.59B 996.99M 2026-03
Cytokinetics USD 1.27B 151.06M 2026-03
Gilead Sciences USD 56.28B 2.74B 2026-03
Heron Therapeutics USD 246.22M 9.66M 2026-03
Immunic USD 189.74M 165.69M 2026-03
Insmed USD 2.08B 188.7M 2026-03
Knight Therapeutics CAD 1.05B 2.28M 2025-12
MacroGenics USD 217.87M 38.97M 2026-03
Omeros USD 200.57M 34.59M 2025-06
Pacira USD 1.21B 56.38M 2026-03
Pfizer USD 207.62B 542M 2026-03
Rockwell Medical USD 52.62M 1.34M 2025-06
Sangamo BioSciences USD 97.56M 11.39M 2025-06
Sarepta Therapeutics USD 3.18B 170.77M 2026-03
United Therapeutics USD 6.71B 1.17B 2026-03
Vertex Pharmaceuticals USD 26.48B 841.4M 2026-03
Xoma USD 263.15M 39.7M 2025-09